Spark Therapeutics (Germany) Profile

41.31
EUR 0.24  0.58%
3%
0%

Spark Therapeutics Summary

Spark Therapeutics Inc (272) is traded on Frankfurt Stock Exchange in Germany. and employs 27 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 1.76 B. Spark Therapeutics Inc has 36.93 M outstanding shares. SPARK THERAPEUTICS has accumulated about 478.7 M in cash with (156.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.94.
Check Spark Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Spark Therapeutics Inc Risk Profiles

Key Fundamentals

Spark Therapeutics Against Markets

Current Ratings

Spark Therapeutics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 74% 
Equity ratings for Spark Therapeutics Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
NameSpark Therapeutics Inc
CEO, Co-Founder, DirectorJeffrey MarrazzoAll Leadership
Macroaxis Advice
InstrumentGermany Stock Stocks Directory
ExchangeFrankfurt Stock Exchange
BenchmarkDOW
CurrencyEUR - Euro

Directors

Spark Therapeutics Corporate Directors
Robert Perez Director
Lars Ekman Independent Director, Ph.D
Lorris Betz Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Directors

Spark Therapeutics Corporate Directors
Robert Perez Director
Lars Ekman Independent Director, Ph.D
Lorris Betz Director